List of Naproxen Sodium drug patents

Naproxen Sodium is owned by Bionpharma Inc.

Naproxen Sodium contains Naproxen Sodium.

Naproxen Sodium has a total of 5 drug patents out of which 0 drug patents have expired.

Naproxen Sodium was authorised for market use on 17 February, 2006.

Naproxen Sodium is available in capsule;oral dosage forms.

Naproxen Sodium can be used as temporary relief of minor aches and pains; temporary reduction of fever.

The generics of Naproxen Sodium are possible to be released after 03 March, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10028925 BIONPHARMA INC Liquid dosage forms of sodium naproxen
Mar, 2026

(3 years from now)

US10022344 BIONPHARMA INC Liquid dosage forms of sodium naproxen
Mar, 2026

(3 years from now)

US11090280 BIONPHARMA INC Liquid dosage forms of sodium naproxen
Mar, 2026

(3 years from now)

US9693979 BIONPHARMA INC Liquid dosage forms of sodium naproxen
Mar, 2026

(3 years from now)

US9693978 BIONPHARMA INC Solvent system for enhancing the solubility of pharmaceutical agents
Mar, 2026

(3 years from now)

Drugs and Companies using NAPROXEN SODIUM ingredient

Market Authorisation Date: 17 February, 2006

Treatment: Temporary relief of minor aches and pains; Temporary reduction of fever

Dosage: CAPSULE;ORAL

How can I launch a generic of NAPROXEN SODIUM before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in